176 related articles for article (PubMed ID: 38116815)
1. Protein tyrosine phosphatases as emerging targets for cancer immunotherapy.
Qu Z; Dong J; Zhang ZY
Br J Pharmacol; 2023 Dec; ():. PubMed ID: 38116815
[TBL] [Abstract][Full Text] [Related]
2. Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies.
Salmond RJ
Cells; 2024 Jan; 13(3):. PubMed ID: 38334623
[TBL] [Abstract][Full Text] [Related]
3. Targeting Tyrosine Phosphatases: Time to End the Stigma.
Stanford SM; Bottini N
Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
[TBL] [Abstract][Full Text] [Related]
4. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
Pulido R; Stoker AW; Hendriks WJ
Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
[TBL] [Abstract][Full Text] [Related]
5. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
6. Targeting protein tyrosine phosphatases for the development of antivirulence agents: Yersinia spp. and Mycobacterium tuberculosis as prototypes.
Menegatti ACO
Biochim Biophys Acta Proteins Proteom; 2022 May; 1870(5):140782. PubMed ID: 35470106
[TBL] [Abstract][Full Text] [Related]
7. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery.
Elhassan RM; Hou X; Fang H
Med Res Rev; 2022 May; 42(3):1064-1110. PubMed ID: 34791703
[TBL] [Abstract][Full Text] [Related]
9. Small molecule targeting of PTPs in cancer.
Lazo JS; McQueeney KE; Burnett JC; Wipf P; Sharlow ER
Int J Biochem Cell Biol; 2018 Mar; 96():171-181. PubMed ID: 28943273
[TBL] [Abstract][Full Text] [Related]
10. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D; Gallagher W; Bennett DC
Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer.
Wang T; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Yu Y; Wang B
Front Immunol; 2022; 13():976996. PubMed ID: 36341348
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford SM; Bottini N
Nat Rev Drug Discov; 2023 Apr; 22(4):273-294. PubMed ID: 36693907
[TBL] [Abstract][Full Text] [Related]
14. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Screening of Substrate Specificity for Protein Tyrosine Phosphatases (PTPs) on Phosphopeptide Microarrays.
Gao L; Lee SS; Chen J; Sun H; Zhao Y; Chai Z; Hu Y
Methods Mol Biol; 2016; 1368():181-96. PubMed ID: 26614076
[TBL] [Abstract][Full Text] [Related]
16. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review).
Chen YL; Hsieh CC; Chu PM; Chen JY; Huang YC; Chen CY
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36660927
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment.
Pardella E; Pranzini E; Leo A; Taddei ML; Paoli P; Raugei G
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003469
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities.
Sharma C; Kim Y; Ahn D; Chung SJ
Arch Pharm Res; 2021 Mar; 44(3):310-321. PubMed ID: 33590390
[TBL] [Abstract][Full Text] [Related]
19. Targeting Receptor-Type Protein Tyrosine Phosphatases with Biotherapeutics: Is Outside-in Better than Inside-Out?
Senis YA; Barr AJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498714
[TBL] [Abstract][Full Text] [Related]
20. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
Barr AJ; Knapp S
Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
